Related references
Note: Only part of the references are listed.Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts
Ronak Rashedi et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
COVID-19 reinfections among naturally infected and vaccinated individuals
Sezanur Rahman et al.
SCIENTIFIC REPORTS (2022)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19
Jonas F. Ludvigsson
ACTA PAEDIATRICA (2021)
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Lauren B. Rodda et al.
CELL (2021)
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler et al.
NATURE (2021)
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie J. Ewer et al.
NATURE MEDICINE (2021)
Immune determinants of COVID-19 disease presentation and severity
Petter Brodin
NATURE MEDICINE (2021)
Hyperinflammation and Immune Response Generation in COVID-19
Kamla Prasad Mishra et al.
NEUROIMMUNOMODULATION (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj et al.
FRONTIERS IN PHYSIOLOGY (2021)
Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease
Tafere Mulaw Belete
INFECTION AND DRUG RESISTANCE (2021)
BNT162b2 mRNA COVID-19 Vaccine: First Approval
Yvette N. Lamb
DRUGS (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Zhiwei Wu et al.
LANCET INFECTIOUS DISEASES (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Adam K. Wheatley et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Nikolaos C. Kyriakidis et al.
NPJ VACCINES (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Jun Wu et al.
NATURE COMMUNICATIONS (2021)
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo Garcia-Montero et al.
VACCINES (2021)
COVID-19: Insights into Potential Vaccines
Ke-Yan Loo et al.
MICROORGANISMS (2021)
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Alberto M. Borobia et al.
LANCET (2021)
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Mine Durusu Tanriover et al.
LANCET (2021)
THE CASE IS GROWING FOR MIX-AND-MATCH COVID VACCINES
Dyani Lewis
NATURE (2021)
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
Tina Schmidt et al.
NATURE MEDICINE (2021)
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Joana Barros-Martins et al.
NATURE MEDICINE (2021)
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Ann R. Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Mixing vaccines may boost immune responses
Gretchen Vogel
SCIENCE (2021)
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
Alyson M. Cavanaugh et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers
Louise Benning et al.
VACCINES (2021)
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Deborah Cromer et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Katharine H. D. Crawford et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Ioannis P. Trougakos et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Toll-like Receptors and the Control of Immunity
Katherine A. Fitzgerald et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
Hong-Yi Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19
Hin Chu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Fan Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
Christopher M. Petrilli et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Irani Thevarajan et al.
NATURE MEDICINE (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
Andrea Padoan et al.
CLINICA CHIMICA ACTA (2020)
Antiviral activities of type I interferons to SARS-CoV-2 infection
Emily Mantlo et al.
ANTIVIRAL RESEARCH (2020)
SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020
Alexandre Belot et al.
EUROSURVEILLANCE (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher et al.
CELL (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A. Juno et al.
NATURE MEDICINE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
Julie Toubiana et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Mimi Guebre-Xabier et al.
VACCINE (2020)
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
Guillaume Beaudoin-Bussieres et al.
MBIO (2020)
Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients
Bing Liu et al.
SCIENTIFIC REPORTS (2020)
Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020
Sapna Bamrah Morris et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Gisela Canedo-Marroquin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Katharina Roltgen et al.
SCIENCE IMMUNOLOGY (2020)
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
Gemma E. Hartley et al.
SCIENCE IMMUNOLOGY (2020)
The immunology of SARS-CoV-2 infections and vaccines
Lilit Grigoryan et al.
SEMINARS IN IMMUNOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Heterogeneity and longevity of antibody memory to viruses and vaccines
Alice Antia et al.
PLOS BIOLOGY (2018)
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
Katherine V. Houser et al.
PLOS PATHOGENS (2017)
Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
Jose L. Nieto-Torres et al.
VIROLOGY (2015)
Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion
Rimpei Morita et al.
IMMUNITY (2011)
Too old to fight? Aging and its toll on innate immunity
G. Hajishengallis
MOLECULAR ORAL MICROBIOLOGY (2010)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)